title: Efficacy of electroconvulsive therapy in Fahr disease associated with bipolar psychotic disorder: a case report.
abstract: We report a case of a patient with Fahr disease affected by bipolar disorder type I with psychotic symptoms. The complex clinical picture, characterized by both neurological and psychiatric symptoms, proved to be partially or completely resistant to several pharmacological trials. On the contrary, a marked improvement of clinical picture occurred after a cycle of 10 sessions of electroconvulsive therapy, followed by a complete and sustained resolution of mood, cognitive, motor, and behavioral symptoms during the next 4 years.
authors.affiliation: Division of Psychiatry, University of Pisa, Pisa, Italy. fcasamassima@hotmail.it
authors.forename: Francesco
authors.initials: F
authors.lastname: Casamassima
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Lattanzi
authors.forename: Roy H
authors.initials: RH
authors.lastname: Perlis
authors.forename: Sara
authors.initials: S
authors.lastname: Fratta
authors.forename: Antonella
authors.initials: A
authors.lastname: Litta
authors.forename: Antonio
authors.initials: A
authors.lastname: Longobardi
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Stange
authors.forename: Alessandro
authors.initials: A
authors.lastname: Tatulli
authors.forename: Giovanni B
authors.initials: GB
authors.lastname: Cassano
mesh_terms: D000339:Affect; D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001007:Anxiety / Q000150:complications / Q000188:drug therapy; D001480:Basal Ganglia Diseases / Q000150:complications* / Q000628:therapy*; D001714:Bipolar Disorder / Q000150:complications* / Q000628:therapy*; D002114:Calcinosis / Q000150:complications* / Q000628:therapy*; D003071:Cognition / Q000502:physiology; D004351:Drug Resistance; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D009068:Movement / Q000502:physiology
chemical_list: D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents